MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Glaukos Corp

Suletud

SektorTervishoid

87.46 4.01

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

83.83

Max

87.46

Põhinäitajad

By Trading Economics

Sissetulek

-1.5M

-20M

Müük

17M

124M

Kasumimarginaal

-15.837

Töötajad

995

EBITDA

12M

-8.6M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+39.23% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. okt 2025

Turustatistika

By TradingEconomics

Turukapital

-456M

5B

Eelmine avamishind

83.45

Eelmine sulgemishind

87.46

Uudiste sentiment

By Acuity

68%

32%

354 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Glaukos Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. okt 2025, 20:45 UTC

Tulu

Costco Wholesale Sales Climb in September, Early October

8. okt 2025, 20:12 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

TaskUs Shares Fall After Holders Reject Take-Private Deal

8. okt 2025, 16:39 UTC

Suurimad hinnamuutused turgudel

Mining Shares Rise as Gold Prices Soar

8. okt 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. okt 2025, 23:43 UTC

Market Talk

Gold Falls on Possible Profit-Taking -- Market Talk

8. okt 2025, 23:18 UTC

Omandamised, ülevõtmised, äriostud

JD Logistics to Finance Acquisition Using Internal Funds

8. okt 2025, 23:17 UTC

Omandamised, ülevõtmised, äriostud

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8. okt 2025, 23:16 UTC

Omandamised, ülevõtmised, äriostud

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8. okt 2025, 21:54 UTC

Market Talk
Tulu

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8. okt 2025, 21:30 UTC

Market Talk

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8. okt 2025, 21:26 UTC

Market Talk
Tulu

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. okt 2025, 19:15 UTC

Market Talk

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8. okt 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8. okt 2025, 18:47 UTC

Market Talk

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8. okt 2025, 18:46 UTC

Omandamised, ülevõtmised, äriostud

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8. okt 2025, 18:46 UTC

Omandamised, ülevõtmised, äriostud

TaskUs Will Remain a Publicly Traded Co >TASK

8. okt 2025, 18:46 UTC

Omandamised, ülevõtmised, äriostud

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8. okt 2025, 18:45 UTC

Omandamised, ülevõtmised, äriostud

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8. okt 2025, 18:07 UTC

Market Talk

Mexico's Inflation Seen Edging Up in September -- Market Talk

8. okt 2025, 16:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Energy & Utilities Roundup: Market Talk

8. okt 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. okt 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. okt 2025, 15:57 UTC

Market Talk

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8. okt 2025, 15:56 UTC

Market Talk

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8. okt 2025, 15:53 UTC

Market Talk

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8. okt 2025, 15:44 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8. okt 2025, 15:44 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8. okt 2025, 15:43 UTC

Omandamised, ülevõtmised, äriostud

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8. okt 2025, 15:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Glaukos Corp Prognoos

Hinnasiht

By TipRanks

39.23% tõus

12 kuu keskmine prognoos

Keskmine 117.08 USD  39.23%

Kõrge 165 USD

Madal 92 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Glaukos Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

11

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

87.61 / 93Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

354 / 371 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
help-icon Live chat